Blocking Connexin-43 may improve diabetic retinopathy, AMD
February 11th 2022Dr. David S. Boyer describes how blocking Connexin-43 may improve the retinal vascular system function in patients with diabetes, potentially creating a future of oral medication for treatment of diabetic retinopathy and AMD.
Analyzing real-world registry study of YUTIQ for chronic non-infectious posterior uveitis
October 12th 2021Ankur Shah, MD, discusses key highlights of his presentation titled "YUTIQ CALM: a real-world registry study of the fluocinolone acetonide intravitreal implant 0.18 mg in chronic non-infectious posterior uveitis," during ASRS 2021.